Lv52
1508 积分 2025-11-19 加入
Population Pharmacokinetics of Tarlatamab, a Half-Life Extended DLL3-Directed Bispecific T-Cell Engager in Patients with Previously Treated Small Cell Lung Cancer
1个月前
已完结
The cell surface glycoprotein CDCP1 in cancer—Insights, opportunities, and challenges
2个月前
已完结
Prospective Identification of Elevated Circulating CDCP1 in Patients Years before Onset of Lung Cancer
2个月前
已完结
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2− Breast Cancers
2个月前
已完结
Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer
2个月前
已完结
CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease
2个月前
已完结
In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling
2个月前
已完结
Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration
2个月前
已完结
Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1
2个月前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
3个月前
已完结
皖公网安备34019202002308
